GEODON , ZELDOX

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Appearance White to slightly yellow uniformly dispersed opaque suspension

Signal word

WARNING

Hazard statements

May cause allergic skin reaction.

Additional information

Short Term Ziprasidone belongs to a class of drugs which have been shown to cause electrocardiogram irregularities and arrhythmia. These effects have not been observed from occupational exposures, however, those with preexisting cardiovascular illnesses may be at increased risk from exposure. Known Clinical Effects This drug is prescribed for antipsychotic therapy and can depress central nervous system function. Adverse effects associated with therapeutic use include sleepiness (somnolence), tiredness, nausea, constipation, dizziness, restlessness, jerky muscle movement, diarrhea, and skin rash. EU Indication of danger Irritant EU Hazard Symbols EU Risk Phrases R43 - May cause sensitization by skin contact. Australian Hazard Classification (NOHSC): Note

Hazardous Ingredients

Non-Dangerous Goods This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.